RF thawing focus Target hospitals and biopharma labs that require controlled, rapid thawing of frozen biological materials, such as blood plasma, to replace or augment current hot air or water bath methods with Antrad’s RF-based solution for improved energy distribution and faster processing times.

Bio-pharma potential Position the technology as a fit for the bio-pharma industry where process control and product quality are critical, emphasizing capability to thaw and warm loads from 100 ml to 50 L with safe, uniform energy delivery and sub-60 minute thaw for 10 L samples.

Global growth angles Leverage Sweden-origin credibility and existing emphasis on blood plasma thawing to expand into medical, food, and precision cooking markets that value consistent energy distribution and scalable throughput.

Tech-enabled selling Highlight the winning tech stack and data-driven capabilities (AWS, analytics, monitoring, and process control) as a differentiator for large institutions seeking auditable, compliant RF-based thawing workflows.

Strategic partnerships Seek collaborations with hospitals, biopharma manufacturers, and contract research organizations to pilot RF thawing solutions, demonstrate performance gains over traditional methods, and create case studies that drive wider adoption.